CELLINI, CLAUDIA
CELLINI, CLAUDIA
Alma Mater Studiorum Universita' di Bologna
Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma
2017 Zannetti, Beatrice Anna; Tacchetti, Paola; Pantani, Lucia; Gamberi, Barbara; Tosi, Patrizia; Rocchi, Serena; Cellini, Claudia; Ronconi, Sonia; Pezzi, Annalisa; Mancuso, Katia; Rizzello, Ilaria; Caratozzolo, Isola; Martello, Marina; Dozza, Luca; Cavo, Michele; Zamagni, Elena
Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial.
2011 Palumbo A.; Cavo M.; Bringhen S.; Zamagni E.; Romano A.; Patriarca F.; Rossi D.; Gentilini F.; Crippa C.; Galli M.; Nozzoli C.; Ria R.; Marasca R.; Montefusco V.; Baldini L.; Elice F.; Callea V.; Pulini S.; Carella A.M.; Zambello R.; Benevolo G.; Magarotto V.; Tacchetti P.; Pescosta N.; Cellini C.; Polloni C.; Evangelista A.; Caravita T.; Morabito F.; Offidani M.; Tosi P.; Boccadoro M.
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study.
2010 Cavo M; Tacchetti P; Patriarca F; Petrucci MT; Pantani L; Galli M; Di Raimondo F; Crippa C; Zamagni E; Palumbo A; Offidani M; Corradini P; Narni F; Spadano A; Pescosta N; Deliliers GL; Ledda A; Cellini C; Caravita T; Tosi P; Baccarani M
First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma.
2006 Tosi P; Zamagni E; Cellini C; Parente R; Cangini D; Tacchetti P; Perrone G; Ceccolini M; Boni P; Tura S; Baccarani M; Cavo M.
Osteonecrosis of the jaws in newly diagnosed multiple myeloma patients treatedwith zoledronic acid and thalidomide-dexamethasone.
2006 Tosi P; Zamagni E; Cangini D; Tacchetti P; Di Raimondo F; Catalano L; D'ArcoA; Ronconi S; Cellini C; Offidani M; Perrone G; Ceccolini M; Brioli A; Tura S;Baccarani M; Cavo M.
Poor outcome with front-line autologous transplantation in t(4;14) multiple myeloma: low complete remission rate and short duration of remission.
2006 Cavo M; Terragna C; Renzulli M; Zamagni E; Tosi P; Testoni N; Nicci C; Cangini D; Tacchetti P; Grafone T; Cellini C; Ceccolini M; Perrone G; Martinelli G; Baccarani M; Guardigni L.
Neurological toxicity of long-term (>1 yr) thalidomide therapy in patients with multiple myeloma.
2005 TOSI P; ZAMAGNI E; CELLINI C; PLASMATI R; CANGINI D; TACCHETTI P; PERRONE; G; PASTORELLI F; TURA S; BACCARANI M.; CAVO M.
Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma.
2005 CAVO M; ZAMAGNI E; TOSI P; TACCHETTI P; CELLINI C; CANGINI D; DE VIVO A; TESTONI N; NICCI C; TERRAGNA C; GRAFONE T; PERRONE G; CECCOLINI M; TURA S; BACCARANI M.; BOLOGNA STUDY.
Assessmen of disease ativity in multiple myeloma with FDG-PET imaging
2004 Fanti S.; Yu JQ; Moretti A.; Farsad M.; Nanni C.; Zamagni E.; Cellini C.; Tosi P.; Zhuangh H.M.; Cavo M.; FRanchi R.; Canini R.; Monetti N.; Alavi A.
First-line therapy with thalidomide and dexamethasone in preparation for autologous stem cell transplantation for multiple myeloma.
2004 Cavo M; Zamagni E; Tosi P; Cellini C; Cangini D; Tacchetti P; Testoni N; Tonelli M; de Vivo A; Palareti G; Tura S; Baccarani M.
Generation of dendritic cells from positively selected CD14+ monocytes for anti-tumor immunotherapy.
2004 A.CURTI; A. ISIDORI; E. FERRI; C. TERRAGNA; NEYROZ P.; C. CELLINI; M. RATTA; M. BACCARANI; R. M. LEMOLI
Thalidomide alone or in combination with dexamethasone in patients with advanced, relapsed or refractory multiple myeloma and renal failure.
2004 TOSI P; ZAMAGNI E; CELLINI C; CANGINI D; TACCHETTI P; TURA S; BACCARANI M.; CAVO M.
Use of FDG-PET imaging for assessment of disease activity in patients with multiple myeloma
2004 Fanti S.; Yu JQ.; Castellucci P.; Moretti A.; Farsad M.; Nanni C.; Zamagni E.; Cellini C.; Tosi P.; Zhuang HM.; Cavo M.; Baccarani M.; Franchi R.; Salizzoni E.; Canini R.; Monetti N.; Alavi A.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma | Zannetti, Beatrice Anna; Tacchetti, Paola; Pantani, Lucia; Gamberi, Barbara; Tosi, Patrizia; Rocc...hi, Serena; Cellini, Claudia; Ronconi, Sonia; Pezzi, Annalisa; Mancuso, Katia; Rizzello, Ilaria; Caratozzolo, Isola; Martello, Marina; Dozza, Luca; Cavo, Michele; Zamagni, Elena | 2017-01-01 | ANNALS OF HEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial. | Palumbo A.; Cavo M.; Bringhen S.; Zamagni E.; Romano A.; Patriarca F.; Rossi D.; Gentilini F.; Cr...ippa C.; Galli M.; Nozzoli C.; Ria R.; Marasca R.; Montefusco V.; Baldini L.; Elice F.; Callea V.; Pulini S.; Carella A.M.; Zambello R.; Benevolo G.; Magarotto V.; Tacchetti P.; Pescosta N.; Cellini C.; Polloni C.; Evangelista A.; Caravita T.; Morabito F.; Offidani M.; Tosi P.; Boccadoro M. | 2011-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study. | Cavo M; Tacchetti P; Patriarca F; Petrucci MT; Pantani L; Galli M; Di Raimondo F; Crippa C; Zamag...ni E; Palumbo A; Offidani M; Corradini P; Narni F; Spadano A; Pescosta N; Deliliers GL; Ledda A; Cellini C; Caravita T; Tosi P; Baccarani M | 2010-01-01 | THE LANCET | - | 1.01 Articolo in rivista | - |
| First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma. | Tosi P; Zamagni E; Cellini C; Parente R; Cangini D; Tacchetti P; Perrone G; Ceccolini M; Boni P; ...Tura S; Baccarani M; Cavo M. | 2006-01-01 | EUROPEAN JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Osteonecrosis of the jaws in newly diagnosed multiple myeloma patients treatedwith zoledronic acid and thalidomide-dexamethasone. | Tosi P; Zamagni E; Cangini D; Tacchetti P; Di Raimondo F; Catalano L; D'ArcoA; Ronconi S; Cellini... C; Offidani M; Perrone G; Ceccolini M; Brioli A; Tura S;Baccarani M; Cavo M. | 2006-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| Poor outcome with front-line autologous transplantation in t(4;14) multiple myeloma: low complete remission rate and short duration of remission. | Cavo M; Terragna C; Renzulli M; Zamagni E; Tosi P; Testoni N; Nicci C; Cangini D; Tacchetti P; Gr...afone T; Cellini C; Ceccolini M; Perrone G; Martinelli G; Baccarani M; Guardigni L. | 2006-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Neurological toxicity of long-term (>1 yr) thalidomide therapy in patients with multiple myeloma. | TOSI P; ZAMAGNI E; CELLINI C; PLASMATI R; CANGINI D; TACCHETTI P; PERRONE; G; PASTORELLI F; TURA ...S; BACCARANI M.; CAVO M. | 2005-01-01 | EUROPEAN JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma. | CAVO M; ZAMAGNI E; TOSI P; TACCHETTI P; CELLINI C; CANGINI D; DE VIVO A; TESTONI N; NICCI C; TERR...AGNA C; GRAFONE T; PERRONE G; CECCOLINI M; TURA S; BACCARANI M.; BOLOGNA STUDY. | 2005-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| Assessmen of disease ativity in multiple myeloma with FDG-PET imaging | Fanti S.; Yu JQ; Moretti A.; Farsad M.; Nanni C.; Zamagni E.; Cellini C.; Tosi P.; Zhuangh H.M.; ...Cavo M.; FRanchi R.; Canini R.; Monetti N.; Alavi A. | 2004-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 4.02 Riassunto (Abstract) | - |
| First-line therapy with thalidomide and dexamethasone in preparation for autologous stem cell transplantation for multiple myeloma. | Cavo M; Zamagni E; Tosi P; Cellini C; Cangini D; Tacchetti P; Testoni N; Tonelli M; de Vivo A; Pa...lareti G; Tura S; Baccarani M. | 2004-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Generation of dendritic cells from positively selected CD14+ monocytes for anti-tumor immunotherapy. | A.CURTI; A. ISIDORI; E. FERRI; C. TERRAGNA; NEYROZ P.; C. CELLINI; M. RATTA; M. BACCARANI; R. M. ...LEMOLI | 2004-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
| Thalidomide alone or in combination with dexamethasone in patients with advanced, relapsed or refractory multiple myeloma and renal failure. | TOSI P; ZAMAGNI E; CELLINI C; CANGINI D; TACCHETTI P; TURA S; BACCARANI M.; CAVO M. | 2004-01-01 | EUROPEAN JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Use of FDG-PET imaging for assessment of disease activity in patients with multiple myeloma | Fanti S.; Yu JQ.; Castellucci P.; Moretti A.; Farsad M.; Nanni C.; Zamagni E.; Cellini C.; Tosi P....; Zhuang HM.; Cavo M.; Baccarani M.; Franchi R.; Salizzoni E.; Canini R.; Monetti N.; Alavi A. | 2004-01-01 | QUARTERLY JOURNAL OF NUCLEAR MEDICINE | - | 4.02 Riassunto (Abstract) | - |